vs
Side-by-side financial comparison of Globe Life (GL) and Option Care Health, Inc. (OPCH). Click either name above to swap in a different company.
Globe Life is the larger business by last-quarter revenue ($1.6B vs $1.4B, roughly 1.2× Option Care Health, Inc.). Globe Life runs the higher net margin — 17.3% vs 3.4%, a 14.0% gap on every dollar of revenue. On growth, Globe Life posted the faster year-over-year revenue change (5.3% vs 1.3%). Over the past eight quarters, Option Care Health, Inc.'s revenue compounded faster (4.9% CAGR vs 4.1%).
Globe Life Inc. (GL) is an American financial services holding company listed on the New York Stock Exchange which operates through its wholly owned subsidiaries providing life insurance, annuity, and supplemental health insurance products. The company is based in McKinney, Texas.
GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...
GL vs OPCH — Head-to-Head
Income Statement — Q1 FY2026 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.4B |
| Net Profit | $270.5M | $45.3M |
| Gross Margin | — | 19.4% |
| Operating Margin | — | 5.4% |
| Net Margin | 17.3% | 3.4% |
| Revenue YoY | 5.3% | 1.3% |
| Net Profit YoY | — | -3.0% |
| EPS (diluted) | $3.39 | $0.29 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | $1.6B | $1.4B | ||
| Q4 25 | $1.5B | $1.5B | ||
| Q3 25 | $1.5B | $1.4B | ||
| Q2 25 | $1.5B | $1.4B | ||
| Q1 25 | $1.5B | $1.3B | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.4B | $1.2B |
| Q1 26 | $270.5M | $45.3M | ||
| Q4 25 | $266.1M | $58.5M | ||
| Q3 25 | $387.8M | $51.8M | ||
| Q2 25 | $252.7M | $50.5M | ||
| Q1 25 | $254.6M | $46.7M | ||
| Q4 24 | $255.2M | $60.1M | ||
| Q3 24 | $303.0M | $53.9M | ||
| Q2 24 | $258.4M | $53.0M |
| Q1 26 | — | 19.4% | ||
| Q4 25 | — | 19.3% | ||
| Q3 25 | — | 19.0% | ||
| Q2 25 | — | 19.0% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 21.3% | ||
| Q3 24 | 26.1% | 20.1% | ||
| Q2 24 | 23.3% | 20.3% |
| Q1 26 | — | 5.4% | ||
| Q4 25 | 21.7% | 6.2% | ||
| Q3 25 | 31.5% | 5.9% | ||
| Q2 25 | 21.2% | 5.8% | ||
| Q1 25 | 21.4% | 5.9% | ||
| Q4 24 | 21.3% | 6.9% | ||
| Q3 24 | 26.3% | 6.7% | ||
| Q2 24 | 23.5% | 6.6% |
| Q1 26 | 17.3% | 3.4% | ||
| Q4 25 | 17.5% | 4.0% | ||
| Q3 25 | 25.6% | 3.6% | ||
| Q2 25 | 17.1% | 3.6% | ||
| Q1 25 | 17.2% | 3.5% | ||
| Q4 24 | 17.4% | 4.8% | ||
| Q3 24 | 20.8% | 4.2% | ||
| Q2 24 | 17.9% | 4.3% |
| Q1 26 | $3.39 | $0.29 | ||
| Q4 25 | $3.28 | $0.37 | ||
| Q3 25 | $4.73 | $0.32 | ||
| Q2 25 | $3.05 | $0.31 | ||
| Q1 25 | $3.01 | $0.28 | ||
| Q4 24 | $3.00 | $0.36 | ||
| Q3 24 | $3.44 | $0.31 | ||
| Q2 24 | $2.83 | $0.30 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $183.8M | $177.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $6.1B | — |
| Total Assets | — | $3.4B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | $183.8M | $177.3M | ||
| Q4 25 | $314.7M | $232.6M | ||
| Q3 25 | $62.8M | $309.8M | ||
| Q2 25 | $116.7M | $198.8M | ||
| Q1 25 | $134.1M | $171.4M | ||
| Q4 24 | $85.0M | $412.6M | ||
| Q3 24 | $100.5M | $483.0M | ||
| Q2 24 | $100.6M | $376.9M |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | $1.2B | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | — | $1.1B | ||
| Q4 24 | — | $1.1B | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $1.1B |
| Q1 26 | $6.1B | — | ||
| Q4 25 | $6.0B | $1.3B | ||
| Q3 25 | $5.7B | $1.4B | ||
| Q2 25 | $5.4B | $1.4B | ||
| Q1 25 | $5.4B | $1.4B | ||
| Q4 24 | $5.3B | $1.4B | ||
| Q3 24 | $4.6B | $1.4B | ||
| Q2 24 | $5.2B | $1.4B |
| Q1 26 | — | $3.4B | ||
| Q4 25 | $30.8B | $3.5B | ||
| Q3 25 | $30.5B | $3.5B | ||
| Q2 25 | $29.8B | $3.4B | ||
| Q1 25 | $29.7B | $3.3B | ||
| Q4 24 | $29.1B | $3.4B | ||
| Q3 24 | $29.6B | $3.4B | ||
| Q2 24 | $28.3B | $3.3B |
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | 0.86× | ||
| Q2 25 | — | 0.82× | ||
| Q1 25 | — | 0.82× | ||
| Q4 24 | — | 0.79× | ||
| Q3 24 | — | 0.78× | ||
| Q2 24 | — | 0.79× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GL
| Life premium | $853.2M | 55% |
| Health premium | $416.9M | 27% |
| Other | $289.5M | 19% |
OPCH
Segment breakdown not available.
